Compared to warfarin, all direct oral anticoagulants (DOACs) were associated with fewer cardiovascular events including heart attacks and strokes in a study of Medicare patients with both nonvalvular atrial fibrillation and heart failure. But apixaban appeared to offer the best balance of protecting against these events while minimizing bleeding risk.

Two papers published March 25 in the Journal of the American College of Cardiology make the case for training other interventionalists, including cardiologists, in performing mechanical thrombectomy to increase access to the emergency stroke treatment.

The promise of artificial intelligence to revolutionize healthcare is the topic of increasing research, with new publications every day devoted to the topic. One of these applications, according to an April 1 article in The Wall Street Journal, is using AI to listen to a person’s voice and detect a range of mental and physical ailments, including coronary artery disease (CAD).

In the latest study to link influenza and cardiovascular disease, researchers found that the most severe flu seasons coincided with spikes in hospitalizations for heart failure.

The proportion of out-of-hospital cardiac arrest (OHCA) patients in Sweden who received bystander CPR increased by 27.4 percent over an 18-year period, according to a new study, with much of that growth attributed to the increased utilization of chest compression-only CPR.

A new report from Australia highlighted the feasibility of transplanting hearts from donors who have experienced circulatory death—a practice which, if adopted, could expand heart transplant volume by an estimated 20 percent.

People who reported waking up in the middle of the night to use the bathroom were 40 percent more likely to have hypertension, according to a study presented March 30 at the Japanese Circulation Society’s annual scientific meeting.

The American Diabetes Association (ADA) issued updates to its 2019 Standards of Medical Care in Diabetes on March 27 in light of recent evidence surrounding icosapent ethyl and dapagliflozin.